- Product Name : Infusion 2.0 + OTOs
- Creator :
- Type : Business Marketing
- Price :
$558
- Size : NaN
- Homepage : Salespage
Infusion 2.0 is a product where James has been able to include High-ticket programs into his daily campaigns, effortlessly bringing in additional $500+ Daily of chunky commissions on top his email marketing campaigns.
What will you get
FE – Infusion 2.0 – $13
- Infusion 2.0 is a product where James has been able to include High-ticket programs into his daily campaigns, effortlessly bringing in additional $500+ Daily of chunky commissions on top his email marketing campaigns.
- This is typically “infusing” additional revenue streams without changing your day to day campaigns.
OTO1 – Infused Money Pages 2.0 - $37
- These pages are the exact pages we use to convert our subscribers into high ticket customers. Building these pages can a lot time and testing to convert.
- But this completely solves this issue as we have these ready made and done for you to start bringing hungry buyers to your offer.
OTO2 – Infusion 2.0 - DFY Package - $197
- Figuring out how to quickly infuse this profitable strategy is half the battle. Getting these chunky $500 - $1000 commissions is even harder…..
- We’ve packaged something very special and unique to really give anyone that implements this a sure fire way to get cash flowing into your wallet.
OTO3 – Infusion 2.0 - Cash Automators - $47
- We’ve gone one further for anyone looking to automate their high ticket campaigns. Getting higher conversions can be tough, but this seamlessly turns prospects into cash buyers.
- These automators will surely bring high profits to your customers.
OTO4 – Infusion 2.0 Unlimited Traffic - $197
- We’ve gone one better with providing anyone multiple and unique methods in tapping into our traffic sources. Targeting buyer traffic is tough, let alone getting regular cold traffic to any offer.
- These traffic methods will surely bring hot card in hand buyers to any offer.
#Infusion 2.0 + OTOs , #imglory
Source :
Infusion 2.0 + OTOs -
0 Comments